These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction]. Thirion X, Barrau K, Micallef J, Haramburu F, Lowenstein W, Sanmarco JL. Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372 [Abstract] [Full Text] [Related]
24. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U. Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [Abstract] [Full Text] [Related]
25. Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence. Compton PA, Ling W, Charuvastra VC, Wesson DR. J Addict Dis; 1995 Sep; 14(3):97-114. PubMed ID: 8555282 [Abstract] [Full Text] [Related]
27. Desipramine treatment of cocaine abuse in methadone maintenance patients. Arndt I, Dorozynsky L, Woody G, McLellan AT, O'Brien CP. NIDA Res Monogr; 1989 Sep; 95():322-3. PubMed ID: 2701300 [No Abstract] [Full Text] [Related]
28. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients. Soyka M, Apelt SM, Lieb M, Wittchen HU. J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826 [Abstract] [Full Text] [Related]
29. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich H, Schneider U. Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668 [Abstract] [Full Text] [Related]
31. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Maremmani I, Pani PP, Pacini M, Perugi G. J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494 [Abstract] [Full Text] [Related]
35. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine]. Haro G, Cervera G, Martínez-Raga J, Pérez-Gálvez B, Fernández-Garcés M, Sanjuan J. Actas Esp Psiquiatr; 2003 Jul; 31(4):205-19. PubMed ID: 12838444 [Abstract] [Full Text] [Related]
36. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Bell J, Mutch C. Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307 [Abstract] [Full Text] [Related]
37. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M. Drug Alcohol Depend; 2006 Jun 28; 83(2):163-8. PubMed ID: 16343811 [Abstract] [Full Text] [Related]